eHealth, Inc.
NASDAQ•EHTH
CEO: Mr. Francis Samuel Soistman Jr.
セクター: Financial Services
業種: Insurance - Brokers
上場日: 2006-10-20
eHealth, Inc. operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Employer and Individual. The Medicare segment offers sale of Medicare-related health insurance plans, which includes Medicare advantage, Medicare Supplement, and Medicare Part D prescription drug plans to Medicare-eligible customers including but not limited to, dental, and vision insurance, as well as advertising program for marketing and other services. The Employer and Individual segment engages in the sale of individual, family, and small business health insurance plans; and ancillary products to non-Medicare-eligible customers including but not limited to, dental, vision, and short and long term disability insurance. In addition, the company provides ecommerce platforms and consumer engagement solutions, which includes market leading information, decision support, customer engagement, and transactional services to group of health insurance consumers; and organize and present the insurance information in objective format to individuals, families, and small businesses to research, analyze, compare and purchase health insurance plans. Further, it markets health insurance plans through its websites, including eHealth.com, eHealthInsurance.com, eHealthMedicare.com, Medicare.com, PlanPrescriber.com, and GoMedigap.com. The company also offers online sponsorship and advertising, non-broker of record, lead referral, technology licensing, as well as performs various post-enrollment services for members in Medicare health insurance plans. eHealth, Inc. was incorporated in 1997 and is headquartered in Austin, Texas.
連絡先情報
13620 Ranch Road 620 North, Suite A250, Austin, TX, 78717, United States
737-248-2340
時価総額
$60.91M
PER (TTM)
1.2
20.9
配当利回り
--
52週高値
$11.36
52週安値
$1.98
52週レンジ
順位55Top 80.0%
2.6
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
弱い • 2.6 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025
財務ダッシュボード
Q3 2025 データ
売上高
$53.87M-7.77%
直近4四半期の推移
EPS
-$1.46-20.22%
直近4四半期の推移
フリーCF
-$28.94M-13.55%
直近4四半期の推移
2025 Q3 決算ハイライト
主なハイライト
Net Loss Significantly Reduced Quarterly Net Loss improved 25.4% to $31.69M in Q3 2025; 9-month loss reduced 30.1% to $84.34M compared to prior year.
Medicare Segment Profitability Medicare segment gross loss improved 79% to $1.15M in Q3 2025, driven by cost reductions across marketing and CC&E expenses.
Strong Cash Flow Generation Generated $19.05M net cash from investing activities in 9 months 2025; operating cash flow reached $10.60M for the same period.
Supplement LTV Rises Constrained LTV for Medicare Supplement members increased 33% to $1,467 K per approved member in Q3 2025, despite MA LTV decline.
リスク要因
Approved Member Volume Drops Total approved members declined 21% in Q3 2025, driven by 29% drop in Medicare Advantage submissions due to regulatory shifts.
High Acquisition Cost Pressure Total acquisition cost per MA-equivalent member rose 19% to $1,489 K in Q3 2025, reflecting higher Customer Care and Enrollment expenses.
Carrier Relationship Concentration Significant revenue concentration exists with few carriers; loss of key relationship or rate reduction severely harms revenue outlook.
Regulatory Compliance Complexity Marketing and sale of Medicare plans face complex, frequently changing federal and state laws, risking fines or license revocation.
見通し
Focus on 2026 AEP Prep Completed Q3 2025 preparations for 2026 AEP; strengthening brand marketing and integrating AI into telephonic enrollment platform.
E&I Diversification Efforts Continuing focus on E&I diversification via ICHRA opportunities, expecting longer execution lead times compared to traditional direct channels.
New CEO Transition Underway Planned CEO transition completed September 2025; new leadership focused on continuity in strategic direction and operational execution.
Liquidity Sufficient for 12 Months Current cash, securities, and expected collections sufficient to fund operations for at least 12 months post-filing date.
同業比較
売上高 (TTM)
RILY$960.24M
$738.34M
$542.95M
粗利益率 (最新四半期)
100.0%
80.5%
80.1%
主要指標
銘柄コード | 時価総額 | PER (TTM) | ROE (TTM) | 負債比率 |
|---|---|---|---|---|
| RILY | $227.95M | 0.8 | -70.8% | 0.0% |
| PEBK | $206.31M | 16.2 | 13.5% | 0.9% |
| UBFO | $194.58M | 15.5 | 9.0% | 1.0% |
長期トレンド
直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
-44.5%
成長鈍化
4四半期純利益CAGR
N/M
収益構造の変化
キャッシュフロー安定性
25%
キャッシュフローに注意が必要
深度リサーチ
次回決算:2026年2月25日
EPS:$2.38
|売上高:-
財務レポート
財務データ
全年度
Form 10-Q - Q3 2025
会計期末: 2025年9月30日|提出日: 2025年11月6日|売上高: $53.87M-7.8%|EPS: $-1.46-20.2%予想を下回るForm 10-Q - Q2 2025
会計期末: 2025年6月30日|提出日: 2025年8月7日|売上高: $60.78M-7.7%|EPS: $-0.98-26.3%予想を上回るForm 10-Q - Q1 2025
会計期末: 2025年3月31日|提出日: 2025年5月7日|売上高: $113.12M+21.7%|EPS: $-0.33-65.6%予想を上回るForm 10-K - FY 2024
会計期末: 2024年12月31日|提出日: 2025年2月27日|売上高: $532.41M+17.6%|EPS: $-1.19+49.8%予想を下回るForm 10-Q - Q3 2024
会計期末: 2024年9月30日|提出日: 2024年11月6日|売上高: $58.41M-9.7%|EPS: $-1.83+8.9%予想を下回るForm 10-Q - Q2 2024
会計期末: 2024年6月30日|提出日: 2024年8月7日|売上高: $65.86M-1.4%|EPS: $-1.33+12.7%予想を下回るForm 10-Q - Q1 2024
会計期末: 2024年3月31日|提出日: 2024年5月7日|売上高: $92.96M+26.1%|EPS: $-0.96-5.0%予想を下回るForm 10-K - FY 2023
会計期末: 2023年12月31日|提出日: 2024年2月29日|売上高: $452.87M+11.7%|EPS: $-2.37+45.6%予想を下回る